Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: Dr Morrow and colleagues1 studied the prognostic value of serial testing of B-type natriuretic peptide (BNP) in patients with unstable coronary artery disease. I am not certain of the validity of their conclusion that changes in BNP levels are associated with long-term clinical outcomes and may provide enhanced decision making in these patients.
Schelbert E. Prognostic Value of B-Type Natriuretic Peptide in Unstable Coronary Artery Disease. JAMA. 2006;295(16):1895-1896. doi:10.1001/jama.295.16.1895-a